Greta Adorni

Title: Greta Adorni: Innovator in Pharmaceutical Formulations

Introduction

Greta Adorni is a prominent inventor based in Noceto, Italy. She has made significant contributions to the field of pharmaceutical formulations, particularly focusing on cysteamine and its derivatives. With a total of 2 patents, her work is paving the way for innovative treatments in various medical conditions.

Latest Patents

Greta's latest patents include a formulation titled "Salt of cysteamine for the preparation of highly respirable particles." This invention provides inhalable microparticles containing cysteamine hyaluronate salt, along with a preparation method and a pharmaceutical composition. Another notable patent is "Formulations of cysteamine and cysteamine derivatives," which describes an oral cysteamine formulation consisting of dry layered lipid matrix microparticles. This formulation is particularly useful for treating cystinosis and neurodegenerative disorders.

Career Highlights

Greta Adorni is currently employed at Recordati Industria Chimica e Farmaceutica S.p.a., where she continues to develop innovative pharmaceutical solutions. Her expertise in the field has led to advancements that benefit patients suffering from complex health issues.

Collaborations

Greta collaborates with esteemed colleagues, including Paolo Colombo and Alessandra Rossi, to further enhance her research and development efforts. Their combined expertise fosters a collaborative environment that drives innovation in pharmaceutical sciences.

Conclusion

Greta Adorni's contributions to the field of pharmaceutical formulations highlight her role as a leading inventor. Her innovative patents and collaborative efforts are making a significant impact on the treatment of various medical conditions.